Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hyperfine, Inc. - Class A Common Stock
(NQ:
HYPR
)
0.9812
-0.0188 (-1.88%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hyperfine, Inc. - Class A Common Stock
< Previous
1
2
3
4
5
Next >
Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
April 17, 2024
From
Hyperfine, Inc.
Via
Business Wire
HYPR Stock Earnings: Hyperfine Beats EPS, Misses Revenue for Q4 2023
March 21, 2024
HYPR stock results show that Hyperfine beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
March 21, 2024
Via
Benzinga
Recap: Hyperfine Q4 Earnings
March 21, 2024
Via
Benzinga
Hyperfine Earnings Preview
March 20, 2024
Via
Benzinga
Recap: Hyperfine Q3 Earnings
November 09, 2023
Via
Benzinga
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
March 21, 2024
From
Hyperfine, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 21, 2024
March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
Via
Benzinga
Hyperfine, Inc. Collaborates with King’s College London to Demonstrate the Swoop® System and UNITY Project to The Princess Royal
March 12, 2024
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024
March 07, 2024
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare Conference
February 28, 2024
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes
February 21, 2024
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. Celebrates Breadth of Swoop® System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational Study
February 01, 2024
From
Hyperfine, Inc.
Via
Business Wire
Why VCI Global Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket
January 12, 2024
Shares of VCI Global Limited (NASDAQ: VCIG) fell sharply in pre-market trading after the company announced pricing of $2.75 million public offering. VCI Global shares tumbled 29.5% to $1.10 in...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 12, 2024
We're starting out the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
Hyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of Use
January 09, 2024
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023
November 20, 2023
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference
November 16, 2023
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. Reports Third Quarter 2023 Financial Results
November 09, 2023
From
Hyperfine, Inc.
Via
GlobeNewswire
Observational Study Finds That Hyperfine, Inc. Portable MR Brain Imaging System Assists Clinicians in Early Detection of Acute Brain Injury in ECMO Patients
November 02, 2023
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. to Announce Third Quarter Financial Results on November 9, 2023
October 19, 2023
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. Announces Promotions of Two Key Clinical Affairs Executives
October 10, 2023
From
Hyperfine, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
October 09, 2023
Via
Benzinga
Hyperfine, Inc. Receives FDA Clearance for Updated AI-powered Software with Improved Image Quality for All Swoop® System Sequences
October 09, 2023
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. to Present at Gilmartin Group Emerging Growth Showcase
September 07, 2023
From
Hyperfine, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 06, 2023
Via
Benzinga
Hyperfine, Inc. Reports Second Quarter 2023 Financial Results
August 14, 2023
From
Hyperfine, Inc.
Via
GlobeNewswire
Enrollment Completed for HOPE PMR Pediatric Hydrocephalus Study Using Hyperfine, Inc. Portable MR Imaging® System
August 09, 2023
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. to Announce Second Quarter Financial Results on August 14, 2023
July 24, 2023
From
Hyperfine, Inc.
Via
Business Wire
Earnings Scheduled For August 14, 2023
August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.